DNDN
DNDN Articles
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Friday morning. AGCO Corporation (NYSE: AGCO) Maintained...
Published:
Last Updated:
Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed...
Published:
Last Updated:
Former Olympus CEO Michael Woodford will sue the troubled company for wrongful dismissal. (Reuters) The International Monetary Fund’s Lagarde says 2012 will not see the end of the euro. (Reuters)...
Published:
US markets opened lower today and finally managed modest gains by mid-afternoon. News from Europe on the reluctance of banks to lend, coupled with an higher-than-expected yield on a French bond issue...
Published:
Last Updated:
The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always the case that some of the top performing stocks each year come from this sector due to the...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Citigroup, Inc. (NYSE: C) Started as Equal-Weight by Evercore...
Published:
Last Updated:
AuthorDendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment. Unfortunately, PROVENGE sales ran slower than expected after the FDA took...
Published:
Last Updated:
Dendreon Corporation (NASDAQ: DNDN) is surging on news that the Centers for Medicare and Medicaid Services will now cover the infusion costs associated with the administration of PROVENGE. Dendreon...
Published:
Though near-term growth visibility for its cancer vaccine Provenge remains cloudy, Seattle-based Dendreon (DNDN) could be an attractive takeover candidate – especially to a major pharmaceutical...
Published:
Last Updated:
Each morning 24/7 Wall St. issues a list of some of the key analyst upgrades, downgrades, and initiations seen from Wall Street research firms. We review these and other calls from the week to see...
Published:
Last Updated:
Stock markets. Equity markets opened sharply higher this morning before falling into negative territory before the ISM and factory order reports were released. The ISM index came in lower than...
Published:
Last Updated:
Medivation, Inc. (NASDAQ: MDVN) is today’s darling in biotech and emerging pharmaceuticals. It and partner Astellas in Japan showed very positive data on its prostate cancer drug candidate. Its...
Published:
Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Aeropostale, Inc. (NYSE: ARO), Dendreon Corporation (NASDAQ:...
Published: